J Grassinger, T Südhoff, R Andreesen, B Hennemann. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/therapeutic useBoronic Acids/therapeutic useBortezomibHematopoietic Stem Cell MobilizationHumansImmunophenotypingLeukemia, Plasma Cell/drug therapyPyrazines/therapeutic useRemission InductionTreatment Outcome
Substances: See more » Antineoplastic AgentsBoronic AcidsPyrazinesBortezomib
Year: 2005 PMID: 16311736 DOI: 10.1007/s00277-005-0027-7
Source DB: PubMed Journal: Ann Hematol ISSN: 0939-5555 Impact factor: 3.673